A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study Of Mometasone Furoate Nasal Spray (MFNS) [mometasone] In Subjects With Mild-Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Associated With Perennial Allergic Rhinitis (PAR) Using Polysomnographic Recordings of Sleep Parameters.

Trial Profile

A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study Of Mometasone Furoate Nasal Spray (MFNS) [mometasone] In Subjects With Mild-Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Associated With Perennial Allergic Rhinitis (PAR) Using Polysomnographic Recordings of Sleep Parameters.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2009

At a glance

  • Drugs Mometasone (Primary)
  • Indications Perennial allergic rhinitis; Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Acronyms TERMINATED
  • Sponsors Schering-Plough
  • Most Recent Events

    • 05 Jan 2009 Acronym identifited as TERMINATED as reported by ClinicalTrials.gov.
    • 05 Jan 2009 Planned end date (Oct 2007) added as reported by ClinicalTrials.gov.
    • 18 Jun 2008 Status changed from recruiting to discontined as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top